Manufacturing Whitepaper: CDMOs at a Crossroads BioSpaceIn this whitepaper, BioSpace reviews the major trends impacting the CDMO sector and the evolving relationship between sponsors and providers.ManufacturingRead full story pharminent April 15, 2026 BioSpace In this whitepaper, BioSpace reviews the major trends impacting the CDMO sector and the evolving relationship between sponsors and providers. ManufacturingRead full story Post navigation Previous: Scientists issue call to arms over antifungal resistanceNext: BMS makes a Beeline, bringing 5 assets to biotech’s $300M precision immunology debut Related Stories Manufacturing BMS banks on Texas for $2.3bn multi-modal manufacturing facility pharminent August 11, 2026 Manufacturing AsymBio to secure $184m to support growth in biologics manufacturing pharminent August 5, 2026 Manufacturing Lilly and Resilience invest $750M in diabetes and obesity drug device supply pharminent July 31, 2026
